CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

imgn-529

mAbexperimentalADC

Clinical trial activity

2 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2012 (NCT01534715)

Timeline

2010s

  1. Jan 1, 2012

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No
Payload
maytansinoid

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • imgn529
  • imgn-529

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02564744Phase 2May 1, 2016Immunogen
NCT01534715Phase 1Jan 1, 2012Immunogen
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
ImmunogenFor profit2222012
1 organizations
Page 1 / 1